A novel class of lipoprotein lipase-sensitive molecules mediates toll-like receptor 2 activation by Porphyromonas gingivalis

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1277-1286

  Jain, Sumita ^a   Coats, Stephen R ^a   Chang, Ana M ^a   Darveau, Richard P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID A; LIPOPOLYSACCHARIDE; LIPOPROTEIN LIPASE; TOLL LIKE RECEPTOR 2;

ARTICLE; FIMBRIA; MOLECULE; MUTANT; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

CELL LINE; HUMANS; INFLAMMATION; LIPOPROTEIN LIPASE; LIPOPROTEINS; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; VIRULENCE FACTORS;

EID: 84875517343     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01036-12     Document Type: Article

References (64)

1. Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8:481-490.
2. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25:134-144.
3. Burns E, Bachrach G, Shapira L, Nussbaum G. 2006. TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J. Immunol. 177:8296-8300.
4. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA. 2011. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10:497-506.
5. Wang M, Shakhatreh MA, James D, Liang S, Nishiyama S, Yoshimura F, Demuth DR, Hajishengallis G. 2007. Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J. Immunol. 179:2349-2358.
6. Medzhitov R, Janeway C, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452-456.
7. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186:869-877.
8. Hajishengallis G, Wang M, Liang S, Triantafilou M, Triantafilou K. 2008. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc. Natl. Acad. Sci. U. S. A. 105:13532-13537.
9. Hajishengallis G, Shakhatreh MA, Wang M, Liang S. 2007. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J. Immunol. 179:2359-2367.
10. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071-1082.
11. Kang JY, Nan X, Jin MS, Youn Ryu S-JYH, Mah S, Han SH, Lee H, Paik S-GLee J-O. 2009. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873-884.
12. Takeuchi O, Kawai T, Mühlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933-940.
13. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. 2002. Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10-14.
14. Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. 2008. TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205-224.
15. Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, Dietsch M, Page RC, Aruffo A. 1995. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 63:1311-1317.
16. Fujiwara T, Ogawa T, Sobue S, Hamada S. 1990. Chemical, immunobiological and antigenic characterizations of lipopolysaccharides from Bacteroides gingivalis strains. J. Gen. Microbiol. 136:319-326.
17. Mansheim BJ, Onderdonk AB, Kasper DL. 1978. Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. J. Immunol. 120:72-78.
18. Ogawa T, Uchida H. 1996. Differential induction of IL-1 beta and IL-6 production by the nontoxic lipid A from Porphyromonas gingivalis in comparison with synthetic Escherichia coli lipid A in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 14:1-13.
19. Chen C, Coats SR, Bumgarner RE, Darveau RP. 2007. Hierarchical gene expression profiles of HUVEC stimulated by different lipid A structures obtained from Porphyromonas gingivalis and Escherichia coli. Cell Microbiol. 9:1028-1038.
20. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. 2009. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4=-phosphatase activities. Cell Microbiol. 11:1587-1599.
21. Jain S, Darveau RP. 2010. Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol. 2000 54:53-70.
22. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. 2004. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect. Immun. 72:5041-5051.
23. Hajishengallis G, Tapping RI, Harokopakis E, Nishiyama S, Ratti P, Schifferle RE, Lyle EA, Triantafilou M, Triantafilou K, Yoshimura F. 2006. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell. Microbiol. 8:1557-1570.
24. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Qureshi N, Michalek SM, Vogel SN. 2001. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-1482.
25. Muthukuru M, Jotwani R, Cutler CW. 2005. Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect. Immun. 73:687-694.
26. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. 2005. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect. Immun. 73:935-943.
27. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. 2000. Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622.
28. Kumada H, Haishima Y, Watanabe K, Hasegawa C, Tsuchiya T, Tanamoto K, Umemoto T. 2008. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide. Oral Microbiol. Immunol. 23:60-69.
29. Ogawa T, Asai Y, Hashimoto M, Takeuchi O, Kurita T, Yoshikai Y, Miyake K, Akira S. 2002. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int. Immunol. 14:1325-1332.
30. Sawada N, Ogawa T, Asai Y, Makimura Y, Sugiyama A. 2007. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis. Clin. Exp. Immunol. 148:529-536.
31. Zhang Y, Gaekwad J, Wolfert MA, Boons GJ. 2008. Synthetic tetraacylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4. Org. Biomol. Chem. 6:3371-3381.
32. Hellman J, Tehan MM, Warren HS. 2003. Murein lipoprotein, peptidoglycan- associated lipoprotein, and outer membrane protein A are present in purified rough and smooth lipopolysaccharides. J. Infect. Dis. 188: 286-289.
33. Lee HK, Lee J, Tobias PS. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 168: 4012-4017.
34. Hashimoto M, Asai Y, Ogawa T. 2004. Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int. Immunol. 16:1431-1437.
35. Asai Y, Hashimoto M, Fletcher HM, Miyake K, Akira S, Ogawa T. 2005. Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling. Infect. Immun. 73:2157-2163.
36. Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA, Darveau RP. 2006. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect. Immun. 74: 4474-4485.
37. Paramonov NA, Aduse-Opoku J, Hashim A, Rangarajan M, Curtis MA. 2009. Structural analysis of the core region of O-lipopolysaccharide of Porphyromonas gingivalis from mutants defective in O-antigen ligase and O-antigen polymerase. J. Bacteriol. 191:5272-5282.
38. Fletcher HM, Schenkein HA, Morgan RM, Bailey KA, Berry CR, Macrina FL. 1995. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect. Immun. 63:1521-1528.
39. Chen T, Dong H, Tang YP, Dallas MM, Malamy MH, Duncan MJ. 2000. Identification and cloning of genes from Porphyromonas gingivalis after mutagenesis with a modified Tn4400 transposon from Bacteroides fragilis. Infect. Immun. 68:420-423.
40. Tokuda M, Chen W, Karunakaran T, Kuramitsu HK. 1998. Regulation of protease expression in Porphyromonas gingivalis. Infect. Immun. 66: 5232-5237.
41. Fujiwara T, Morishima S, Takahashi I, Hamada S. 1993. Molecular cloning and sequencing of the fimbrilin gene of Porphyromonas gingivalis strains and characterization of recombinant proteins. Biochem. Biophys. Res. Commun. 197:241-247.
42. Yoshimura F, Takahashi K, Nodasaka Y, Suzuki T. 1984. Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis. J. Bacteriol. 160:949-957.
43. Nichols FC, Riep B, Mun J, Morton MD, Bojarski MT, Dewhirst FE, Smith MB. 2004. Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis. J. Lipid Res. 45:2317-2330.
44. Vallabhapurapu S, Karin M. 2009. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol. 27:693-733.
45. Asai Y, Ohyama Y, Gen Ogawa KT. 2001. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect. Immun. 69:7387-7395.
46. Davey M, Liu X, Ukai T, Jain V, Gudino C, Gibson FC, Golenbock D, Visintin A, Genco CA. 2008. Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs. J. Immunol. 180:2187-2195.
47. Makimura Y, Asai Y, Taiji Y, Sugiyama A, Tamai R, Ogawa T. 2006. Correlation between chemical structure and biological activities of Porphyromonas gingivalis synthetic lipopeptide derivatives. Clin. Exp. Immunol. 146:159-168.
48. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
49. Nichols FC, Bajrami B, Clark RB, Housley W, Yao X. 2012. Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples. Infect. Immun. 80:860-874.
50. Mead JR, Irvine SA, Ramji DP. 2002. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80:753-769. 51. Kovacs-Simon A, Titball RW, Michell SL. 2011. Lipoproteins of bacterial pathogens. Infect. Immun. 79:548-561.
51. Kovacs-Simon A, Titball RW, Michell SL. 2011. Lipoproteins of bacterial pathogens. Infect. Immun. 79:548-561.
52. Coats SR, Berezow AB, To TT, Jain S, Bainbridge BW, Banani KP, Darveau RP. 2011. The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria. Infect. Immun. 79:203-210.
53. Manthey CL, Vogel SN. 1994. Elimination of trace endotoxin protein from rough chemotype LPS. J. Endotoxin Res. 1:84-91.
54. Nishikawa K, Yoshimura F, Duncan MJ. 2004. A regulation cascade controls expression of Porphyromonas gingivalis fimbriae via the FimR response regulator. Mol. Microbiol. 54:546-560.
55. Shimada E, Kataoka H, Miyazawa Y, Yamamoto M, Igarashi T. 2012. Lipoproteins of Actinomyces viscosus induce inflammatory responses through TLR2 in human gingival epithelial cells and macrophages. Microbes Infect. 14:916-921.
56. Aoki Y, Tabeta K, Murakami Y, Yoshimura F, Yamazaki K. 2010. Analysis of immunostimulatory activity of Porphyromonas gingivalis fimbriae conferred by Toll-like receptor 2. Biochem. Biophys. Res. Commun. 398:86-91.
57. Shoji M, Yoshimura A, Yoshioka H, Takade A, Takuma Y, Yukitake H, Naito M, Hara Y, Yoshida Nakayama S-IK. 2010. Recombinant Porphyromonas gingivalis FimA preproprotein expressed in Escherichia coli is lipidated and the mature or processed recombinant FimA protein forms a short filament in vitro. Can. J. Microbiol. 56:959-967.
58. Nichols FC, Housley WJ, O'Conor CA, Manning T, Wu S, Clark RB. 2009. Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity. Am. J. Pathol. 175:2430-2438.
59. Machata S, Tchatalbachev S, Mohamed W, Jänsch Hain LT, Chakraborty T. 2008. Lipoproteins of Listeria monocytogenes are critical for virulence and TLR2-mediated immune activation. J. Immunol. 181: 2028-2035.
60. Bagaitkar J, Demuth DR, Daep CA, Renaud DE, Pierce DL, Scott DA. 2010. Tobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity. PLoS One 5:e9323. doi:10.1371/journal.pone .0009323.
61. Eskan MA, Hajishengallis G, Kinane DF. 2007. Differential activation of human gingival epithelial cells and monocytes by Porphyromonas gingivalis fimbriae. Infect. Immun. 75:892-898.
62. Hajishengallis G, Ratti P, Harokopakis E. 2005. Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors. J. Biol. Chem. 280:38902-38913.
63. Zhou Q, Amar S. 2007. Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components. J. Immunol. 179:7777-7790.
64. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:974-977.